2016 Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Bone Marrow Transplant.
2016 Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Paviglianiti A Journal Haematologica.
2016 Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cremers EM Journal Ann Hematol.
2016 Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gratwohl A Journal Ann Hematol.
2016 Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). Group Chronic Malignancies Working Party (CMWP) 1st listed author Bruno B Journal Leuk Lymphoma.
2015 Efficacy and outcome of allogeneic transplantation in IgD and non secretory myeloma. A report on behalf of the myeloma subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Morris C Journal Biol Blood Marrow Transplant.
2015 Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Blood
2015 Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial. Group Chronic Malignancies Working Party (CMWP) 1st listed author Iacobelli S Journal Bone Marrow Transplant.
2015 Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multigenerational study of the European Society of Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Haematologica
2015 Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger NM Journal Leukemia
2015 Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2014 Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Chalandon Y Journal Haematologica